Pacira BioSciences, Inc. (PCRX) NASDAQ

26.15

+0.29(+1.12%)

Updated at May 19 04:00PM

Currency In USD

Pacira BioSciences, Inc.

Address

5401 West Kennedy Boulevard

Tampa, FL 33609

United States of America

Phone

813 553 6680

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

788

First IPO Date

February 03, 2011

Key Executives

NameTitlePayYear Born
Mr. Frank D. LeeChief Executive Officer & Director3.15M1968
Mr. Shawn M. CrossChief Financial Officer566,7871968
Mr. Anthony Molloy III, Esq.Chief Legal & Compliance Officer581,4101974
Mr. David M. StackAdvisor727,3781950
Ms. Kristen Williams Esq., J.D.Chief Administrative Officer & Secretary1M1974
Dr. Jonathan Slonin M.D.Chief Medical Officer1.03M1975
Mr. Charles A. Reinhart III, CPA, M.B.A.Executive Officer1.06M1961
Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior Vice President of Finance1.95M1979
Ms. Susan MescoHead of Investor Relations0N/A
Mr. Christopher C. YoungChief Manufacturing Officer01972

Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.